Reasonable incomplete revascularization

Circulation

Volumn 123, Issue 21, 2011, Pages 2337-2340

  Dauerman, Harold L ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

coronary artery bypass grafting; percutaneous treatment; revascularization

Indexed keywords

CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; INCOMPLETE CORONARY ARTERY REVASCULARIZATION; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL REVASCULARIZATION; RISK FACTORS;

EID: 79958084942     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.033126     Document Type: Review

References (20)

1. Buda AJ, Macdonald IL, Anderson MJ, Strauss HD, David TE, Berman ND. Long-term results following coronary bypass operation. Importance of preoperative actors and complete revascularization. J Thorac Cardiovasc Surg. 1981;82:383-890.
2. Kleisli T, Cheng W, Jacobs MJ, Mirocha J, Derobertis MA, Kass RM, Blanche C, Fontana GP, Raissi SS, Magliato KE, Trento A. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2005;129:1283-1291.
3. Hannan EL, Racz M, Holmes DR, King SB III, Walford G, Ambrose JA, Sharma S, Katz S, Clark LT, Jones RH. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006;113:2406-2412. (Pubitemid 43948048)
4. Hannan EL, Wu C, Walford G, Holmes DR, Jones RH, Sharma S, King SB III. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. J Am Coll Cardiol Cardiovasc Interv. 2009;2:17-25.
5. Van Den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. 2002;39:559-564. (Pubitemid 34158148)
6. Kirschbaum SW, Springeling T, Boersma E, Moelker A, van Der Giessen WJ, Serruys PW, de Feyter PJ, van Geuns RJ. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre-and post-procedural evaluation by cardiac magnetic resonance imaging. J Am Coll Cardiol Cardiovasc Interv. 2010;3:392-400.
7. Kim Y-H, Park D-W, Lee J-Y, Kim W-J, Yun S-C, Ahn J-M, Song HG, Oh J-H, Park JS, Kang S-J, Lee S-W, Lee CW, Park S-W, Park S-J. Impact of angiographic complete revascularization after drug-eluting stent implantation or coronary artery bypass surgery for multivessel coronary artery disease. Circulation. 2011;123:2373-2381.
8. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, Van Den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-972.
9. Rastan AJ, Walther T, Falk V, Kempfert J, Merk D, Lehmann S, Holzhey D, Mohr FW. Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery? Circulation. 2009;120:S70-S77.
10. Srinivas VS, Selzer F, Wilensky RL, Holmes DR, Cohen HA, Monrad ES, Jacobs AK, Kelsey SF, Williams DO, Kip KE. Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: a report from the NHLBI Dynamic Registry. J Interv Cardiol. 2007;20:373-380. (Pubitemid 47429137)
11. Teirstein PS. The dueling hazards of incomplete revascularization and incomplete data. Circulation. 2006;113:2380-2382. (Pubitemid 43948044)
12. Vander Salm TJ, Kip KE, Jones RH, Schaff HV, Shemin RJ, Aldea GS, Detre KM. What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 2002;39:565-572. (Pubitemid 34158149)
13. Sarno G, Garg S, Onuma Y, Gutiérrez-Chico JL, Van Den Brand MJ, Rensing BJ, Morel MA, Serruys PW. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study). Am J Cardiol. 2010;106:1369-1375.
14. Cohen DJ, Van HB, Serruys PW, Mohr FW, Macaya C, Den Heijer P, Vrakking MM, Wang K, Mahoney EM, Audi S, Leadley K, Dawkins KD, Kappetein AP. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med. 2011;364:1016-1026.
15. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schönberger JP, Buller N, Bonser R, Van Den Brand MJ, van Herwerden LA, Morel MA, van Hout BA. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344: 1117-1124. (Pubitemid 32285232)
16. Holubkov R, Laskey WK, Haviland A, Slater JC, Bourassa MG, Vlachos HA, Cohen HA, Williams DO, Kelsey SF, Detre KM. Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry. Am Heart J. 2002;144:826-833. (Pubitemid 35335174)
17. Behan MW, Holm NR, Curzen NP, Erglis A, Stables RH, de Belder AJ, Niemelä M, Cooter N, Chew DP, Steigen TK, Oldroyd KG, Jensen JS, Lassen JF, Thuesen L, Hildick-Smith D. Simple or complex stenting for bifurcation coronary lesions: a patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Circ Cardiovasc Interv. 2011;4:57-64.
18. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516. (Pubitemid 46588415)
19. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008; 117:1283-1291. (Pubitemid 351365675)
20. Tonino PA, De BB, Pijls NH, Siebert U, Ikeno F, van't Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213-224.